Possible role of mucosal mast cells in the recovery process of colitis induced by dextran sulfate sodium in rats

International Immunopharmacology

Volumn 3, Issue 4, 2003, Pages 485-491

  Iba, Yoshinori ^a,b   Sugimoto, Yukio ^b   Kamei, Chiaki ^b   Masukawa, Tohru ^a  

^a SETSUNAN UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Colitis; Dextran sulfate sodium; Mucosal mast cells; Rat mast cell protease; Spontaneous recovery process

Indexed keywords

CHYMASE; DEXTRAN SULFATE; MYELOPEROXIDASE; WATER;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL PROLIFERATION; COLITIS; CONTROLLED STUDY; CRYPT CELL; DEGRANULATION; DEPLETION; ENZYME ACTIVITY; EPITHELIOID CELL; GOBLET CELL; HISTOLOGY; INFLAMMATORY CELL; MALE; MAST CELL; MUCOSA CELL; NONHUMAN; PRIORITY JOURNAL; RAT; RECTUM; RECTUM MUCOSA; SURFACE PROPERTY;

EID: 0037390592     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(02)00299-0     Document Type: Article

References (24)

1. King T., Biddle W., Bhatia P., Moore J., Miner P.B. Jr. Colonic mucosal mast cell distribution at line of demacation of active ulcerative colitis. Dig. Dis. Sci. 37:1992;490-495.
2. Lloyd G., Green F.H.Y., Fox H., Mani V., Turnberg L.A. Mast cells and immunoglobulin E in inflammatory bowel disease. Gut. 16:1975;861-866.
3. Nolte H., Spjeldnaes N., Kruse A., Windelborg B. Histamine release from gut mast cells from patients with inflammatory bowel diseases. Gut. 31:1990;791-794.
4. O'Sullivan M., Clayton N., Breslin N.P., Harman I., Bountra C., McLaren A.et al. Increased mast cells in the irritable bowel syndrome. Neurogastroenterol. Motil. 12:2000;449-457.
5. Gelbmann C.M., Mestermann S., Gross V., Köllinger M., Schölmerich J., Falk W. Structures in Crohn's disease are characterised by an accumulation of mast cells colocalised with laminin but not with fibronectin or vitronectin. Gut. 45:1999;210-217.
6. Hawkins R.A., Claman H.N., Clark R.A.F., Steigerwald J.C. Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis? Ann. Intern. Med. 102:1985;182-186.
7. Armbrust T., Batusic D., Ringe B., Ramadori G. Mast cells distribution in human liver disease and experimental rat liver fibrosis. Indications for mast cell participation in development of liver fibrosis. J. Hepatol. 26:1997;1042-1054.
8. Kawanami O., Ferrans V.J., Fulmer J.D., Crystal R.G. Ultrastructure of pulmonary mast cells in patients with fibrotic lung disorders. Lab. Invest. 40:1979;717-734.
9. Pesci A., Bertorelli G., Gabrielli M., Olivieri D. Mast cells in fibrotic lung disorders. Chest. 103:1993;989-996.
10. Artuc M., Hermes B., Steckelings U.M., Grützkau A., Henz B.M. Mast cells and their mediators in cutaneous wound healing-active participants or innocent bystanders? Exp. Dermatol. 8:1999;1-16.
11. Okayasu I., Hatakeyama S., Yamada M., Ohkusa T., Inagaki Y., Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 98:1990;694-702.
12. Iba Y., Sugimoto Y., Kamei C. Participation of mast cells in colitis inflammation induced by dextran sulfate sodium. Methods Find. Exp. Clin. Pharmacol. 24:2002;15-18.
13. Araki Y., Andoh A., Fujiyama Y., Bamba T. Development of dextran sulphate sodium-induced experimental colitis is suppressed in genetically mast cell-deficient Ws/Ws rats. Clin. Exp. Immunol. 119:2000;264-269.
14. Wingren U., Enerbäck L. Mucosal mast cells of the rat intestine: a re-evaluation of fixation and staining properties, with special reference to protein blocking and solubility of the granular glycosaminoglycan. Histochem. J. 15:1983;571-582.
15. Brown J.F., Chafee K.A., Tepperman B.L. Role of mast cells, neutrophils and nitric oxide in endotoxin-induced damage to the neonatal rat colon. Br. J. Pharmacol. 123:1998;31-38.
16. Bradley P.P., Priebat D.A., Christensen R.D., Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 78:1982;206-209.
17. Huntley J.F., Mackellar A., Newlands G.F.J., Irvine J., Miller H.R.P. Mapping of the rat mast cell granule proteinases RMCP I and II by enzyme-linked immunosorbent assay and paired immunofluorescence. APMIS. 98:1990;933-944.
18. Rioux K.P., Wallace J.L. Long-term antigen challenge results in progressively diminished mucosal mast cell degranulation in rats. Gastroenterology. 111:1996;1516-1523.
19. Dieleman L.A., Ridwan B.U., Tennyson G.S., Beagley K.W., Bucy R.P., Elison C.O. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology. 107:1994;1643-1652.
20. Kanwar S., Kubes P. Mast cells contribute to ischemia-reperfusion-induced granulocyte infiltration and intestinal dysfunction. Am. J. Physiol. 267:1994;G316-G321.
21. Stein J., Ries J., Barrett K.E. Disruption of intestinal barrier function associated with experimental colitis: possible role of mast cells. Am. J. Physiol. 274:1998;G203-G209.
22. Nakajima S., Arizono N., Hattori T., Bamba T. Increase in mucosal and connective tissue-type mast cells in the stomach with acetic acid-induced ulcer in rat. APMIS. 104:1996;19-29.
23. Chan A., Cooley M.A., Collins A.M. Mast cells in the rat liver are phenotypically heterogeneous and exhibit features of immaturity. Immunol. Cell Biol. 79:2001;35-40.
24. Stenton G.R., Vliagoftis H., Befus A.D. Role of intestinal mast cells in modulating gastrointestinal pathophysiology. Ann. Allergy Asthma Immunol. 81:1998;1-11.